Clinical researchAcute coronary syndromesGender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes: Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative
Abbreviations and acronyms
Cited by (0)
The CRUSADE initiative is funded by Millennium Pharmaceuticals Inc. (Cambridge, Massachusetts) and Schering Corp. (Kenilworth, New Jersey). Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership provides an unrestricted grant in support of the program. Drs. Peterson and Roe serve on the Speakers' Bureau for Millennium Pharmaceuticals Inc. and Schering Corp. Dr. Roe serves on the speakers' bureau for Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Drs. Peterson, Roe, Ohman, Gibler, and Newby have research grants from Millennium Pharmaceuticals Inc., and research grants from Schering Corp. Drs. Peterson, Boden, Roe, Ohman, Gibler, and Newby have research grants from Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Dr. Diercks has consulting relationships with Millennium Pharmaceuticals Inc. and Schering Corp.